GlassScriptPhysician profile
Brandon Gough
NPI 1053537779
$42,145.32
in general payments reported to CMS, 2019-2025
15 companies · $973 in 2025
The $973 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $3,769 · 2021: $5,383 · 2022: $11K · 2023: $4,179 · 2024: $2,021 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,835 · Consulting Fee: $3,000 · Travel and Lodging: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,835.18 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $338.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $19,500.82 | 2019-2025 | Mako, Triathlon, Motionsense Digital Goniometer |
| Zimmer Biomet Holdings, INC. | $13,422.56 | 2021-2023 | Rosa, Persona |
| Smith+Nephew, INC. | $3,095.98 | 2019-2025 | Birmingham Hip, Pico 7, Evos |
| Think Surgical, INC. | $2,289.11 | 2022 | |
| Heron Therapeutics, INC. | $2,000.00 | 2021 | |
| Depuy Synthes Sales INC. | $706.63 | 2020-2025 | Tfn-Advance, Emphasys, Kincise |
| Total Joint Orthopedics, INC. | $303.04 | 2024 | |
| Medtronic, INC. | $278.67 | 2025 | Plasmablade(Tm), Intellis Adaptivestim, Aquamantys(Tm) |
| Medtronic USA, INC. | $268.65 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $102.12 | 2021 | |
| Encore Medical, LP | $96.00 | 2022 | |
| Theragen, INC. | $30.01 | 2023 | Kneehab Xp |
| Kerecis Limited | $19.52 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Vericel Corporation | $18.06 | 2024 | Maci |
| Molnlycke Health Care US, LLC | $14.15 | 2024 | Mepilex Border Post-Op Ag, Avance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Gough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.